Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - LONG-TERM DEBT
Long-term Debt SRPT - Sarepta Therapeutics, Inc.
1.27 B
LAST VALUE
5.77%
2 YEAR CAGR
24.81%
5 YEAR CAGR
95.32%
10 YEAR CAGR